Literature DB >> 10522605

Pharyngo-esophageal motility disturbances in patients with myotonic dystrophy.

I Modolell1, F Mearin, J S Baudet, J Gámez, C Cervera, J R Malagelada.   

Abstract

BACKGROUND: Esophageal motility is often disturbed in patients with myotonic dystrophy. The esophageal motor derangement pattern and its correlation with esophageal and peripheral motor symptoms is not well defined. Our aims were to evaluate: 1) pharyngo-esophageal motor abnormalities in these patients; 2) the relationship between motor involvement and clinical manifestations; and 3) the correlation between pharyngo-esophageal motility abnormalities and peripheral neuromuscular involvement.
METHODS: We compared data from 18 patients and 18 healthy controls. Neuromuscular affectation was quantified with a five-point muscular disability rating scale. Pharyngo-esophageal symptoms were assessed with a directed questionnaire, whereas motility was evaluated by means of manometry.
RESULTS: Myotonic dystrophy patients had diminished pharyngeal contraction amplitude, upper esophageal sphincter basal pressure, and esophageal body contraction amplitude compared with the control group (P < 0.001). No signs of esophageal myotony were evident. Simultaneous esophageal waves after more than 40% of liquid swallows were found in 80% of patients. No relationship between esophageal manometric alteration and esophageal or peripheral motility symptoms was elicited.
CONCLUSION: In patients with myotonic dystrophy pharyngo-esophageal motility is severely deranged in both amplitude and coordination. These abnormalities may be present even if symptoms referred by the patient or the severity of the disease is not remarkable.

Entities:  

Mesh:

Year:  1999        PMID: 10522605     DOI: 10.1080/003655299750025336

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

Review 1.  Oropharyngeal dysphagia in myotonic dystrophy type 1: a systematic review.

Authors:  Walmari Pilz; Laura W J Baijens; Bernd Kremer
Journal:  Dysphagia       Date:  2014-01-24       Impact factor: 3.438

Review 2.  Diagnosis and management of cricopharyngeal achalasia and other upper esophageal sphincter opening disorders.

Authors:  I J Cook
Journal:  Curr Gastroenterol Rep       Date:  2000-06

Review 3.  Gastrointestinal manifestations in myotonic muscular dystrophy.

Authors:  Massimo Bellini; Sonia Biagi; Cristina Stasi; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Santino Marchi
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

4.  [High resolution manometry study of pharyngeal function in patients with myotonic dystrophy].

Authors:  M Jungheim; D Kühn; M Ptok
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

Review 5.  Neuromuscular imaging in inherited muscle diseases.

Authors:  Mike P Wattjes; Rudolf A Kley; Dirk Fischer
Journal:  Eur Radiol       Date:  2010-04-27       Impact factor: 5.315

6.  Steinert's syndrome presenting as anal incontinence: a case report.

Authors:  Fusun Erdenen; Ahmet Burak Toros; Ayse Kubat Uzum; Sirin Sacak
Journal:  J Med Case Rep       Date:  2011-08-12

7.  High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.

Authors:  James E Hilbert; Richard J Barohn; Paula R Clemens; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Amy L Parkhill; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  Neurology       Date:  2017-08-30       Impact factor: 9.910

8.  Steakhouse Syndrome in Myotonic Dystrophy.

Authors:  Nobuhiko Ogasawara; Kenichiro Sato; Michiko Tsutsumiuchi; Mami Kanzaki; Yoshikazu Uesaka
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

9.  Characteristics of tongue and pharyngeal pressure in patients with neuromuscular diseases.

Authors:  George Umemoto; Hirokazu Furuya; Yoshio Tsuboi; Shinsuke Fujioka; Hajime Arahata; Miwa Sugahara; Mitsuaki Sakai
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-05-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.